Extending treatment effects from a randomized trial using observational data: an application to coronary thrombus aspiration
Matthews, A. A.; Dahabreh, I. J.; Frobert, O.; Lindahl, B.; James, S.; Feychting, M.; Jernberg, T.; Berglund, A.; Hernan, M.
Show abstract
To increase confidence in the use of observational analyses when addressing effectiveness questions beyond those addressed by randomized trials, one can first benchmark the observational analyses against existing trial results. We use Swedish registry data to emulate a target trial similar to the TASTE randomized trial, which found no difference in the risk of death or myocardial infarction by 1 year with or without thrombus aspiration among individuals with ST-elevation myocardial infarction. We benchmark the emulation against the trial at 1 year, then extend the emulations follow up to 3 years and estimate effects in subpopulations underrepresented in the trial. As in the TASTE trial, the observational analysis found no differences in risk of outcomes by 1 year between groups (risk difference 0.7 (-0.7,2.0) and -0.2 (-1.3,1.0) for death and myocardial infarction respectively), so benchmarking was considered successful. We additionally show no difference in risk of death or myocardial infarction by 3 years, or within subpopulations by 1 year. Benchmarking against an index trial before using observational analyses to answer questions beyond those the trial could address allowed us to explore whether the observational data can be trusted to deliver valid estimates of treatment effects.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Trials that turn from retrospectively registered to prospectively registered: A cohort study of ‘retroactively prospective’ clinical trial registration using history data 93%
- Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY disease (CLARITY): Statistical analysis plan for a randomised controlled Bayesian adaptive sample size trial 93%
- UKCTOCS Update: Applying insights of delayed effects in cancer screening trials to the long-term follow-up mortality analysis 93%
Similar papers in this journal
- The effect of coronary revascularization treatment timing on mortality in patients with stable ischemic heart disease in British Columbia 94%
- Actionable absolute risk prediction of atherosclerotic cardiovascular disease: a behavior-management approach based on data from 464,547 UK Biobank participants 92%
- Using numerical modelling and simulation to assess the ethical burden in clinical trials and how it relates to the proportion of responders in a trial sample 92%
Similar papers in this journal
- Large-scale validation of the Prediction model Risk Of Bias ASsessment Tool (PROBAST) using a short form: high risk of bias models show poorer discrimination 93%
- Results reporting for clinical trials led by medical universities and university hospitals in the Nordic countries was often missing or delayed 92%
- Results dissemination from clinical trials conducted at German university medical centres was delayed and incomplete 92%
Similar papers in this journal
- A Systematic Review of Machine Learning-based Prognostic Models for Acute Pancreatitis: Towards Improving Methods and Reporting Quality 91%
- Differential impact of Covid-19 on incidence of diabetes mellitus and cardiovascular diseases in acute, post-acute and long Covid-19: population-based cohort study in the United Kingdom 90%
- Accuracy and clinical effectiveness of risk prediction tools for pressure injury occurrence: An umbrella review 90%
Similar papers in this journal
- Bias amplification of unobserved confounding in pharmacoepidemiological studies using indication-based sampling: there is no free lunch in restricting the sample to those with a particular drug-indication 91%
- Using quantitative bias analysis to adjust for misclassification of COVID-19 outcomes: An applied example of inhaled corticosteroids and COVID-19 outcomes 91%
- Benzodiazepine Initiation Effect on Mortality Among Medicare Beneficiaries Post Acute Ischemic Stroke 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.